XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 276,102 $ 570,934
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Investment income (43,106) (60,033)
Net realized and unrealized (gain) loss from consolidated funds’ investments 10,546 (183,260)
Accretion of original issue and market discount of consolidated funds’ investments, net (43,869) (52,021)
Income distributions from corporate investments in funds and companies 171,867 68,390
Other non-cash items 0 3,450
Cash flows due to changes in operating assets and liabilities:    
Net cash provided (used) in operating activities 543,663 (508,604)
Cash flows from investing activities:    
Purchases of U.S. Treasury and other securities 0 (250,000)
Proceeds from maturities and sales of U.S. Treasury and other securities 0 80,000
Corporate investments in funds and companies 0 (36,756)
Distributions and proceeds from corporate investments in funds and companies 65,081 162,490
Net cash provided (used) by investing activities 65,081 (44,266)
Cash flows from financing activities:    
Capital contributions 119,433 37,229
Net cash (used) provided by financing activities (768,155) 871,469
Effect of exchange rate changes on cash    
Effect of exchange rate changes on cash (68) (8,830)
Net increase (decrease) in cash and cash-equivalents (159,479) 309,769
Supplemental Cash Flow Information [Abstract]    
Deconsolidation due to restructuring 0 (8,805)
Initial consolidation (deconsolidation) of funds 0 (108,345)
Cash, Cash Equivalents    
Cash and cash-equivalents, beginning balance 449,851 336,679
Cash and cash-equivalents, ending balance 290,372 529,298
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 290,372 529,298
Oaktree    
Cash flows due to changes in operating assets and liabilities:    
Increase in other assets (14,798) (5,820)
(Increase) decrease in net due from affiliates (525) 209,317
Decrease in accrued compensation expense (68) (91,953)
Decrease in accounts payable, accrued expenses and other liabilities (292) (465)
Cash flows from financing activities:    
Distributions to Class A unitholders (408,324) (211,591)
Distributions to OCGH unitholders 0 (82,212)
Distributions to preferred unitholders (20,487) (20,487)
Cash, Cash Equivalents    
Cash and cash-equivalents, ending balance 8,587 20,841
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents 8,587 20,841
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Decrease in accounts payable, accrued expenses and other liabilities 11,380 (31,739)
Decrease (increase) in dividends and interest receivable 11,051 (8,723)
Decrease (increase) in receivables for investments sold (1,406) 30,707
Decrease in other assets 10,938 42,660
(Decrease) increase in payables for investments purchased (23,791) 118,789
Purchases of investments (1,779,534) (3,134,754)
Proceeds from maturities and sales of investments 1,959,168 2,015,917
Cash flows from financing activities:    
Contributions from non-controlling interests 633,232 271,806
Distributions to non-controlling interests (789,826) (399,650)
Payment of debt issuance costs 0 (3,378)
Borrowings on credit facilities 963,095 2,187,422
Repayments on credit facilities (1,265,278) (907,670)
Cash, Cash Equivalents    
Cash and cash-equivalents, ending balance 281,785 508,457
Reconciliation of cash and cash-equivalents    
Total cash and cash-equivalents $ 281,785 $ 508,457